In this video, Ethan Smith, Nuvolo’s VP and Head of Strategy & Operations, explains why asset utilisation and performance tracking are critical for life sciences organisations—even though their core focus is health and innovation. He shares how many companies overlook the financial impact of underutilised assets or inefficient vendor contracts, which can quietly drain budgets and limit production capacity.
Ethan walks through how implementing asset reservation and utilisation tracking tools—like those offered by Nuvolo—can give teams better visibility into what equipment is available, how often it’s being used, and where gaps might exist. This kind of insight helps organisations make smarter decisions about whether to repair, replace, or expand their equipment inventory, while ensuring teams have what they need to stay productive and compliant.